Remternetug
Remternetug is a human immunoglobulin G1-kappa, anti-APP (amyloid beta A4 precursor protein) Aβ42 N3pGlu peptide monoclonal antibody. Remternetug recognizes a pyroglutamated form of Aβ. Remternetug results in rapid and robust amyloid plaque reduction. Remternetug can be used for Alzheimer's disease research[1][2].
Product Specifications
CAS Number
2571940-41-3
Product Name Alternative
LY3372993
UNSPSC
12352203
Target
Amyloid-β
Type
Inhibitory Antibodies
Related Pathways
Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/remternetug.html
Purity
99.00
Solubility
10 mM in DMSO
Smiles
[Remternetug]
Molecular Weight
(144.916 kDa)
References & Citations
[1]Li-Kai Huang, et al. Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update. J Biomed Sci. 2023 Oct 2;30 (1) :83.|[2]Meglio M. Alzheimer Disease Pipeline Update: Inside Look at Promising Agents. Neurology Live, 2023: NA-NA.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
